Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
22.83%
17.44%
17.58%
16.86%
15.93%
14.59%
Sector average
-19.57%
-18.86%
21.26%
45.9%
27.83%
13.61%
ROA
22.27%
17.4%
17.54%
16.83%
15.91%
14.56%
Sector average
-4.19%
-6.68%
-24.58%
1.77%
-29.44%
7.73%
Gross Margin
100%
100%
100%
100%
Amounts in CHF (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as â-â. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for BB Biotech AG? It covers the balance sheet, income statement and Equlion model projections.
100%
100%
Sector average
40.44%
40.6%
40.6%
40.6%
40.6%
40.6%
Net Margin
98.49%
98.52%
98.48%
98.45%
98.43%
98.42%
Total Assets
CHFÂ 2,785,759.00K
CHFÂ 3,316,187.35K
CHFÂ 3,955,306.64K
CHFÂ 4,683,173.68K
CHFÂ 5,493,499.01K
CHFÂ 6,357,116.48K
Sector average
CHFÂ 6,583,664.69K
CHFÂ 7,029,775.91K
CHFÂ 7,875,113.17K
CHFÂ 8,842,325.96K
CHFÂ 9,880,548.85K
CHFÂ 10,888,357.41K
Net Income
CHFÂ 578,133.00K
CHFÂ 530,998.87K
CHFÂ 637,827.79K
CHFÂ 726,791.51K
CHFÂ 809,327.51K
CHFÂ 862,968.96K
Sector average
CHFÂ 509,037.80K
CHFÂ 497,738.03K
CHFÂ 567,206.48K
CHFÂ 655,953.18K
CHFÂ 738,044.20K
CHFÂ 795,142.15K
Valuation
CHFÂ 2,356,102.80K
CHFÂ 2,402,022.35K
CHFÂ 2,446,638.48K
CHFÂ 2,490,482.90K
CHFÂ 2,533,775.77K
CHFÂ 2,577,352.67K
Sector average
CHFÂ 12,182,569.70K
CHFÂ 13,169,956.24K
CHFÂ 13,319,586.58K
CHFÂ 13,502,659.68K
CHFÂ 13,728,881.51K
CHFÂ 13,908,079.25K
Stock Price
CHFÂ 42.72
CHFÂ 43.55
CHFÂ 44.36
CHFÂ 45.16
CHFÂ 45.94
CHFÂ 46.73
Sector average
CHFÂ 102.74
CHFÂ 98.77
CHFÂ 102.59
CHFÂ 107.21
CHFÂ 112.19
CHFÂ 115.32
BB Biotech AG (BION.SW) Financial Forecast | Equlion
